The conserved hypothetical protein Rv0574c is required for cell wall integrity, stress tolerance, and virulence of Mycobacterium tuberculosis

Infection and Immunity

Volumn 83, Issue 1, 2015, Pages 120-129

  Garg, Rajni ^a   Tripathi, Deeksha ^a   Kant, Sashi ^b,c   Chandra, Harish ^b,d   Bhatnagar, Rakesh ^a   Banerjee, Nirupama ^a,b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBON DIOXIDE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LYSOZYME; NITRIC OXIDE; POLYGLUTAMIC ACID; RIFAMPICIN; RV0574C PROTEIN; UNCLASSIFIED DRUG; PEPTIDE; PEPTIDE SYNTHASE; POLYGLUTAMINE; POLYGLUTAMYL SYNTHETASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CELL GROWTH; CELL HYPOXIA; CONTROLLED STUDY; DELETION MUTANT; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GENE LOCUS; GRANULOMA; GROWTH CURVE; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; MACROPHAGE; MECHANICAL STRESS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN SYNTHESIS; SPLEEN; TUBERCULAR GRANULOMA; TUBERCULOSIS; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL WALL; CHEMISTRY; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MONOCYTE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; VIRULENCE;

ANIMALS; BIOFILMS; CELL WALL; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; HUMANS; LUNG; MICE, INBRED BALB C; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE SYNTHASES; PEPTIDES; SPLEEN; STRESS, PHYSIOLOGICAL; TUBERCULOSIS; VIRULENCE;

EID: 84919485498     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02274-14     Document Type: Article

References (44)

1. World Health Organization. 2012. Global tuberculosis report. World Health Organization, Geneva, Switzerland.
2. Portevin D, De Sousa-D'Auria C, Houssin C, Grimaldi C, Chami M, Daffé M, Guilhot C. 2004. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A 101:314-319. http://dx.doi.org/10.1073/pnas.0305439101.
3. Portevin D, de Sousa-D'Auria C, Montrozier H, Houssin C, Stella A, Lanéelle M-A, Bardou F, Guilhot C, Daffé M. 2005. The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase component. J Biol Chem 280:8862-8874. http://dx.doi.org/10.1074/jbc.M408578200.
4. Musayev F, Sachdeva S, Scarsdale JN, Reynolds KA, Wright HT. 2005. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroylcoenzyme A. J Mol Biol 346:1313-1321. http://dx.doi.org/10.1016/j.jmb.2004.12.044.
5. Wietzerbin J, Lederer F, Petit JF. 1975. Structural study of poly-Lglutamic acid of Mycobacterium tuberculosis var. hominis Brevannes. Biochem Biophys Res Commun 62:246-252. http://dx.doi.org/10.1016/S0006-291X(75)80130-6.
6. Hirschfield GR, McNeil M, Brennan PJ. 1990. Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol 172:1005-1013.
7. Harth G, Horwitz MA. 1999. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 189:1425-1436. http://dx.doi.org/10.1084/jem.189.9.1425.
8. Harth G, Zamecnik PC, Tang JY, Tabatadze D, Horwitz MA. 2000. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci U S A 97:418-423. http://dx.doi.org/10.1073/pnas.97.1.418.
9. Tullius MV, Harth G, Horwitz MA. 2003. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect Immun 71:3927-3936. http://dx.doi.org/10.1128/IAI.71.7.3927-3936.2003.
10. Chandra H, Basir SF, Gupta M, Banerjee N. 2010. Glutamine synthetase encoded by glnA-1 is necessary for cell wall resistance and pathogenicity of Mycobacterium bovis. Microbiology 156:3669-3677. http://dx.doi.org/10.1099/mic.0.043828-0.
11. Krajewski WW, Collins R, Holmberg-Schiavone L, Jones TA, Karlberg T, Mowbray SL. 2008. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. J Mol Biol 375:217-228. http://dx.doi.org/10.1016/j.jmb.2007.10.029.
12. Candela T, Fouet A. 2006. Poly-gamma-glutamate in bacteria. Mol Microbiol 60:1091-1098. http://dx.doi.org/10.1111/j.1365-2958.2006.05179.x.
13. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 198:693-704. http://dx.doi.org/10.1084/jem.20030846.
14. Rohde KH, Abramovitch RB, Russell DG. 2007. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2:352-364. http://dx.doi.org/10.1016/j.chom.2007.09.006.
15. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
16. Howard NS, Gomez JE, Ko C, Bishai WR. 1995. Color selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector. Gene 166:181-182. http://dx.doi.org/10.1016/0378-1119(95)00597-X.
17. Guérout-Fleury A-M, Shazand K, Frandsen N, Stragier P. 1995. Antibiotic-resistance cassettes for Bacillus subtilis. Gene 167:335-336. http://dx.doi.org/10.1016/0378-1119(95)00652-4.
18. Pelicic V, Jackson M, Reyrat JM, Jacobs WR, Gicquel B, Guilhot C. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94:10955-10960. http://dx.doi.org/10.1073/pnas.94.20.10955.
19. MacKenzie SL, Hodge LR. 1977. Gas chromatography-mass spectrometry of the N(O)-heptafluorobutyryl isobutyl esters of the protein amino acids using electron impact ionisation. J Chromatogr 132:485-493. http://dx.doi.org/10.1016/S0021-9673(00)82912-X.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Bligh EG, Dyer WJ. 1959. A rapid method of total lipidextraction and purification. Can J Biochem Physiol 37:911-917. http://dx.doi.org/10.1139/o59-099.
22. Banaei N, Kincaid EZ, Lin S-YG, Desmond E, Jacobs WR, Ernst JD. 2009. Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green. Antimicrob Agents Chemother 53:3799-3802. http://dx.doi.org/10.1128/AAC.00647-09.
23. Palomino J, Martin A, Camacho M, Guerra H, Swings J, Portaels F. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2720-2722. http://dx.doi.org/10.1128/AAC.46.8.2720-2722.2002.
24. Hu Y, Coates ARM. 2011. Mycobacterium tuberculosis acg gene is required for growth and virulence in vivo. PLoS One 6:e20958. http://dx.doi.org/10.1371/journal.pone.0020958.
25. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB KR. 1999. Genetic approaches to study of biofilms. Methods Enzymol 310:91-109. http://dx.doi.org/10.1016/S0076-6879(99)10008-9.
26. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR, Hatfull GF. 2008. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69:164-174. http://dx.doi.org/10.1111/j.1365-2958.2008.06274.x.
27. Shiloh MU, Manzanillo P, Cox JS. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3:323-330. http://dx.doi.org/10.1016/j.chom.2008.03.007.
28. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198:705-713. http://dx.doi.org/10.1084/jem.20030205.
29. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci U S A 98: 7534-7539. http://dx.doi.org/10.1073/pnas.121172498.
30. Kumar A, Deshane JS, Crossman DK, Bolisetty S, Yan B-S, Kramnik I, Agarwal A, Steyn AJC. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J Biol Chem 283:18032-18039. http://dx.doi.org/10.1074/jbc.M802274200.
31. Park H-D, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, Schoolnik GK, Sherman DR. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48:833-843. http://dx.doi.org/10.1046/j.1365-2958.2003.03474.x.
32. Sousa EHS, Tuckerman JR, Gonzalez G, Gilles-Gonzalez M-A. 2007. DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis. Protein Sci 16:1708-1719. http://dx.doi.org/10.1110/ps.072897707.
33. Shi L, Jung Y-J, Tyagi S, Gennaro ML, North RJ. 2003. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcriptionpatterncharacteristic ofnonreplicatingpersistence. Proc Natl Acad Sci USA 100:241-246. http://dx.doi.org/10.1073/pnas.0136863100.
34. Purkayastha A, McCue LA, McDonough KA. 2002. Identification of a Mycobacterium tuberculosis putative classical nitroreductase gene whose expression is coregulated with that of the acr gene within macrophages, in standing versus shaking cultures, and under low oxygen conditions. Infect Immun 70:1518-1529. http://dx.doi.org/10.1128/IAI.70.3.1518-1529.2002.
35. Yuan Y, Crane DD, Simpson RM, Zhu YQ, Hickey MJ, Sherman DR, Barry CE. 1998. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 95:9578-9583. http://dx.doi.org/10.1073/pnas.95.16.9578.
36. Hu Y, Coates ARM. 1999. Transcription of the stationary-phaseassociated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilodalton protein. J Bacteriol 181:1380-1387.
37. Florczyk MA, McCue LA, Purkayastha A, Currenti E, Wolin MJ, Kathleen A, McDonough KA. 2003. A family of acr-coregulated Mycobacterium tuberculosis genes shares a common DNA motif and requires Rv3133c (dosR or devR) for expression. Infect Immun 71:5332-5343. http://dx.doi.org/10.1128/IAI.71.9.5332-5343.2003.
38. Guyton A. 1991. Textbook of medical physiology. W. B. Saunders, Philadelphia, PA.
39. Cunningham AF, Spreadbury CL. 1998. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 180:801-808.
40. Raymond JB, Mahapatra S, Crick DC, Pavelka MS. 2005. Identification of the namH gene, encoding the hydroxylase responsible for the Nglycolylation of the mycobacterial peptidoglycan. J Biol Chem 280:326-333. http://dx.doi.org/10.1074/jbc.M411006200.
41. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318.
42. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625. http://dx.doi.org/10.1126/science.1099390.
43. Roberts ME, Stewart PS. 2005. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology 151:75-80. http://dx.doi.org/10.1099/mic.0.27385-0.
44. Pavelka MS, Jacobs WR. 1999. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J Bacteriol 181:4780-4789.